Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
Global sustainable funds faced net outflows of approximately USD 55 billion in Q3 2025, a sharp reversal from the USD 5.8 billion inflows in the previous quarter. This shift was driven primarily by ...
Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results